IDH2 and glioma: This indicates that all patients with IDH mutant tumors have similar survival regardless of their tumors’ ATRX, TERTp, or chr1p19q status and IDH wildtype glioma (Grp7 and Grp8) showed significantly worse survival compared to IDH mutant gliomas.